Physician profile
Jae Hee Cho
NPI 1962814343
$16,265.95
in general payments reported to CMS, 2019-2025
29 companies · $1,129 in 2025
The $1,129 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $2,978 · 2021: $7,360 · 2022: $2,441 · 2023: $947 · 2024: $1,294 · 2025: $1,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,370.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,561.05 | 2021-2025 | Hawkone, Heli-Fx Endoanchor System, Endurant Iis |
| Medtronic Vascular, INC. | $2,884.13 | 2020 | |
| W. L. Gore & Associates, INC. | $1,510.46 | 2021-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Abbott Laboratories | $1,487.09 | 2022-2024 | Esprit |
| Cook Medical LLC | $1,113.84 | 2021-2025 | Cook, Zenith Spiral-Z, Fusion |
| Stryker Corporation | $374.02 | 2025 | Clottriever Bold Catheter, Flowtriever, Ct Thrombectomy System Kit |
| Inari Medical, INC. | $263.69 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $249.13 | 2024-2025 | Krystexxa |
| Shockwave Medical, INC | $186.99 | 2020-2021 | |
| Tactile Systems Technology INC | $183.89 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Silk Road Medical, INC. | $168.64 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $162.97 | 2021 | |
| Thd America, INC. | $153.86 | 2024 | |
| Lemaitre Vascular, INC. | $148.66 | 2022-2025 | Artegraft Vascular Graft, Pruitt F3 Carotid Shunt |
| Penumbra, INC. | $140.50 | 2023 | Penumbra System |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $129.63 | 2023 | Treo Abdominal Stent-Graft System |
| Kci USA, INC. | $106.87 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $102.12 | 2022 | |
| Horizon Therapeutics Plc | $98.32 | 2023 | Krystexxa |
| Ethicon US, LLC | $87.07 | 2019 | |
| Terumo Medical Corporation | $22.07 | 2022 | |
| Z-Medica, LLC | $18.75 | 2019 | |
| Lilly USA, LLC | $18.50 | 2025 | Zepbound |
| Novo Nordisk INC | $18.15 | 2023 | |
| Solventum Corporation | $17.28 | 2025 | Prevena |
| Glaxosmithkline, LLC. | $15.94 | 2024 | Trelegy Ellipta |
| Abbvie INC. | $15.86 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.49 | 2023 | Xifaxan, Trulance |
| Getinge USA Sales, LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jae Hee Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.